Head-to-head comparisons of medication uses, side effects, warnings, and more.
Xtandi (enzalutamide) and nilutamide (Nilandron) are both oral medications used to treat metastatic prostate cancer, but they have some differences. Both medications are taken by mouth once a day, but nilutamide is typically only taken for a few weeks after starting a LHRH agonist. Common side effects while on Xtandi are weakness and back pain, while those taking nilutamide commonly experience hot flashes, difficulty with night vision, and nausea. Xtandi can increase the risk of seizures and heart problems, whereas nilutamide has the risk of serious liver and lung problems. While Xtandi is only available as a brand-name medication, nilutamide is available as a lower-cost generic option.
Xtandi (enzalutamide) is a prescription cancer medication used to treat certain types of prostate cancer in adults. It works by blocking testosterone, a hormone that many prostate cancers need to grow. You usually take a tablet or capsule once a day by mouth, often along with other hormone treatments or after surgery to remove the testicles. Common side effects include weakness or fatigue, back pain, and hot flashes.
Nilutamide (Nilandron) is taken by mouth and used to treat metastatic prostate cancer, meaning cancer that has spread to other parts of the body. It’s a form of hormonal therapy called an androgen receptor inhibitor or antiandrogen, that works to block testosterone in your body. Nilutamide (Nilandron) is one of the recommended options for prostate cancer and is taken once a day. It can cause hot flashes and make it difficult for your eyes to adjust at night, which can be bothersome.
Side effects experienced by people who took nilutamide (Nilandron) after surgical castration:
Side effects experienced by people who took nilutamide (Nilandron) with leuprolide (a LHRH agonist):
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.